Sionex Continues to Strengthen its Patent Portfolio

Sionex Corporation has announced that the US Patent Office has issued a further seven patents to add to its existing portfolio.

The newly issued US patents;

7,119,328 B2: System for DMS peak resolution.

7,098,449: Spectrometer chip assembly.

7,091,481 B2: Method and apparatus for plasma generation.

7,075,068 B2: Method and apparatus for electrospray augmented high field asymmetric ion mobility spectrometer.

7,045,776 B2: System for collection of data and identification of unknown ion species.

7,030,372: Micromachined field asymmetric ion mobility filter and detection.

7,057,168: Systems for differential mobility analysis.

These newly issued patents add to Sionex’s core IP for the microDMx™ technology and further extend its applicability for a wide range of analysis, monitoring and detection scenarios.

The microDMx technology allows the detection of chemical compounds down to parts per trillion (ppt) levels with a degree of specificity unmatched by any other current technology.

"Sionex is continually strengthening our patent portfolio as a key strategy," said Raanan Miller, Sionex’s founder and chief technology officer.

"Part of that strategy is to foster and develop key relationships and collaborations with world-class research institutes and academia."

"We still have an extremely close relationship with The Charles Stark Draper Laboratory in Cambridge, MA, for developments and improvements to our technology."